Improving cervical cancer screening and treatment in low-resource settings
Research Project 2
This study is looking at a new way to help women in South Africa get tested and treated for cervical cancer more easily and affordably, using a quick HPV test that can be done right in their local clinics.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Columbia University Health Sciences NIH-funded |
| Lab location | 1 site (New York, United States) |
| Project ID | NIH-10931485 on NIH RePORTER |
What this research studies
This research focuses on enhancing cervical cancer screening and treatment in low and middle-income countries, particularly through the implementation of HPV-based testing followed by immediate treatment. It aims to evaluate the costs and effectiveness of a new point-of-care HPV DNA test in public primary care settings in South Africa. By collaborating with local institutions, the project seeks to develop tailored strategies for the widespread adoption of this screening method, addressing both financial and operational challenges. The study will assess the cost-effectiveness of the screening process to ensure equitable access for women in these communities.
Who could benefit from this research
Good fit: Ideal candidates for this research are women living in low and middle-income countries, particularly those in public primary care settings who are at risk for cervical cancer.
Not a fit: Patients who do not reside in low and middle-income countries or those who are not at risk for cervical cancer may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could significantly reduce cervical cancer mortality rates among women in low-resource settings by improving access to effective screening and treatment.
How similar studies have performed: Previous research has shown success with similar HPV-based screening approaches, indicating potential for effective implementation in diverse settings.
Where this research is happening
New York, United States
- Columbia University Health Sciences — New York, United States (Active)
Researchers
- Principal investigator: Moodley, Jennifer Rose — Columbia University Health Sciences
- Study coordinator: Moodley, Jennifer Rose
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.